PFND vs GILD: Which Stock is Better?
Side-by-side comparison of Pathfinder Cell Therapy Inc and Gilead Sciences Inc in 2026
PFND
Pathfinder Cell Therapy Inc
$0.00
GILD
Gilead Sciences Inc
$135.87
Key Metrics Comparison
| Metric | PFND | GILD | Winner |
|---|---|---|---|
| Market Cap | $0.07M | $170.84B | GILD |
| P/E Ratio | N/A | 20.27 | GILD |
| EPS (TTM) | $N/A | $6.79 | GILD |
| Revenue Growth | 0.0% | 0.0% | GILD |
| Gross Margin | 0.0% | 78.8% | GILD |
Analyze PFND
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PFND or GILD a better investment?
Comparing PFND and GILD: Pathfinder Cell Therapy Inc has a market cap of $0.07M while Gilead Sciences Inc has $170.84B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PFND and GILD?
PFND (Pathfinder Cell Therapy Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PFND or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: PFND or GILD?
GILD has higher revenue growth at 0.0% vs 0.0% for PFND.
Which company is more profitable: PFND or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to 0.0% for PFND.
Which is the larger company: PFND or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $170.84B compared to $0.07M for PFND.
Should I buy PFND or GILD in 2026?
Both PFND and GILD have investment merit. PFND trades at $0.00 while GILD trades at $135.87. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PFND and GILD stock?
Key differences: Market Cap ($0.07M vs $170.84B), P/E Ratio (N/A vs 20.3x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 78.8%).